
Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year
Author(s) -
Sumit Randhir Singh,
Ravi Parikh,
Yoichi Sakurada,
Bhushan Uplanchiwar,
Ahmad M. Mansour,
Abhilash Goud,
Yasha S. Modi,
Jay Chhablani
Publication year - 2020
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.519
H-Index - 9
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.4103/tjo.tjo_3_20
Subject(s) - medicine , pro re nata , macular degeneration , aflibercept , bevacizumab , visual acuity , exudative age related macular degeneration , ophthalmology , retrospective cohort study , ranibizumab , surgery , chemotherapy